Abdullah Y. A. Alzahrania,
Wesam S. Shehab*b,
Asmaa H. Amerb,
Mohamed G. Assyb,
Samar M. Mouneirc,
Maged Abdelazizb and
Atef M. Abdel Hamidb
aDepartment of Chemistry, Faculty of Science and Arts, King Khalid University, Mohail Assir, Saudi Arabia. E-mail: ayalzahrani@kku.edu.sa
bDepartment of Chemistry, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt. E-mail: dr.wesamshehab@gmail.com; wsshehab@zu.edu.eg
cDepartment of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Cairo, 12211, Egypt
First published on 13th November 2024
Correction for ‘Design, synthesis, pharmacological evaluation, and in silico studies of the activity of novel spiro pyrrolo[3,4-d]pyrimidine derivatives’ by Abdullah Y. A. Alzahrani et al., RSC Adv., 2024, 14, 995–1008, https://doi.org/10.1039/D3RA07078F.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2024 |